Literature DB >> 1897976

Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions.

S T Olson1, P E Bock, R Sheffer.   

Abstract

A variation of the quantitative affinity chromatography (QAC) method of Winzor, Chaiken, and co-workers for the analysis of protein-ligand interactions has been developed and used to characterize sequence-specific and nonspecific protein-heparin interactions relevant to blood coagulation. The method allows quantitation of the binding of two components, A and B, from the competitive effect of one component, B, on the partitioning of the other component, A, between an immobilized acceptor phase and solution phase at equilibrium. Under the conditions employed, the differences in total A concentrations yielding an equivalent degree of saturation of the immobilized acceptor in the absence and presence of B defines the concentration of A bound to B in solution, thereby enabling conventional Scatchard or nonlinear least-squares analysis of the A-B equilibrium interaction. Like the QAC method, quantitation of the competitor interaction does not depend on the nature of the affinity matrix interaction, which need only be described empirically. The additional advantage of the difference method is that only the total rather than the free competitor ligand concentration need be known. The method requires that the partitioning component A be univalent, but allows for multivalency in the competitor, B, and can in principle be used to study binding interactions involving nonidentical, interacting, or nonspecific overlapping sites. Both the binding constant and the stoichiometry for the specific antithrombin-heparin interaction as well as the apparent binding constant for the nonspecific thrombin-heparin interaction at low thrombin binding densities obtained using this technique were in excellent agreement with values determined using spectroscopic probes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897976     DOI: 10.1016/0003-9861(91)90076-u

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.

Authors:  T A Brighton; Y P Dai; P J Hogg; C N Chesterman
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

3.  Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells.

Authors:  E Stratikos; E Alberdi; P G Gettins; S P Becerra
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

4.  Interaction of platelet-derived growth factor with thrombospondin 1.

Authors:  P J Hogg; K A Hotchkiss; B M Jiménez; P Stathakis; C N Chesterman
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.

Authors:  Peter Panizzi; Rainer Friedrich; Pablo Fuentes-Prior; Heather K Kroh; Judy Briggs; Guido Tans; Wolfram Bode; Paul E Bock
Journal:  J Biol Chem       Date:  2005-10-17       Impact factor: 5.157

6.  Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.

Authors:  Sophia Schedin-Weiss; Benjamin Richard; Rebecka Hjelm; Steven T Olson
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

7.  The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly.

Authors:  Raffaella Toso; Hua Zhu; Rodney M Camire
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

8.  Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation.

Authors:  Ingrid M Verhamme; Paul E Bock
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

9.  Factor VII mutant V154G models a zymogen-like form of factor VIIa.

Authors:  Raffaella Toso; Francesco Bernardi; Theresa Tidd; Mirko Pinotti; Rodney M Camire; Giovanna Marchetti; Katherine A High; Eleanor S Pollak
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.